ID   Lu-99B
AC   CVCL_2801
SY   LU-99B; Lu99B; LU99B
DR   CLO; CLO_0037029
DR   CLO; CLO_0050042
DR   cancercelllines; CVCL_2801
DR   Cosmic; 1066166
DR   JCRB; JCRB0057
DR   LINCS_LDP; LCL-1909
DR   RCB; RCB1971
DR   TKG; TKG 0496
DR   Wikidata; Q54903213
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Doubling time: 18.2 hours (Note=Lot 062294) (JCRB=JCRB0057).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0057; RCB=RCB1971; TKG=TKG 0496
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4452; Lung giant cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3015 ! Lu-99
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 22
//
RX   PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D;
RA   Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T.,
RA   Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M.,
RA   Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.;
RT   "Screening the p53 status of human cell lines using a yeast functional
RT   assay.";
RL   Mol. Carcinog. 19:243-253(1997).
//